Spotlight on Annals

Management of chronic urticaria, therapies for atopic dermatitis and the role of filaggrin in AD


January 13, 2020

Happy New Year!  For many of us, 2019 absolutely flew by.  As new information, new consensus and new guidelines continue to emerge, keeping up with what may seem to be familiar diseases and syndromes remains paramount to providing the best possible care for our patients.  Accordingly, the emphasis for our January issue of the Annals of Allergy, Asthma and Immunology is allergic skin diseases. There are several articles that I would like to mention as good reads with great educational messages.

Spotlight on Annals


December 23, 2019

Christmas Day is right around the corner. Hopefully everyone (whether you personally celebrate Christmas or not) will have some down time coming with the new year holiday. This will be a perfect time to peruse the December issue of the Annals of Allergy, Asthma and Immunology.  I am pleased to offer a few suggestions for those interested.

First, as I hope you have noticed, the Annals has had an uptick in the number of articles that are short and to the point, allowing readers to gain new information in a matter of minutes. A prime component of this is our Letters feature. We typically have 10 – 12 letters per issue on a variety of topics that will interest a broad percentage of our readers. I encourage you to check them out.

Choosing the right biologic for severe patients, the continuum of worsening asthma and an exacerbation and treatment options for yellow zone patients


October 28, 2019

Next week many of us will gather in Houston for our Annual Meeting. There will be many learning opportunities, including great information on asthma. I thought I would point out a few more articles in the October issue to recommend for your reading pleasure and information. It is a great way to spend a cool autumn afternoon/evening.

Asthma management in children, viral infections and asthma and management of patients with asthma-COPD overlap


October 14, 2019

Well, we are all finally into the fall season in North America and there are signs of autumn everywhere  ̶  even in the deep South where we have had amazingly warm weather to date. It is finally cooling down. All the football teams (high school, college, pros) are far enough into their seasons that the playoff picture is beginning to come into focus. That will allow many of us to slow down a bit and take time to peruse the October issue of the Annals of Allergy, Asthma and Immunology. I want to provide my thoughts on the whole issue and particularly some “don’t miss” reading opportunities.

Use of injectable epinephrine by a specific device, prevalence of CD163+ macrophages in lung tissue in fatal asthma patients, and an editorial on asthma therapy targeting macrophages


September 23, 2019

By now, all of you should have received your September issue of the Annals of Allergy, Asthma and Immunology. While our monthly emphasis has been in pharmacoeconomics, I want to be sure you have looked at some of our other features in this issue. I would like to call your attention to two, in particular.

Cost-effectiveness of food allergy management in infants and economic considerations of biologics to treat CRS


September 9, 2019

Happy September everyone! Football season is here (along with weed pollen in many parts of the country), kids are back in school. And we are all looking for upcoming regulatory changes that will likely provide economic challenges for many of us who care for patients, both community and academic based. This month’s issue of the Annals of Allergy, Asthma and Immunology emphasizes the pharmacoecomomics of allergy practice. We have collected several fine pieces from experts who have provided thought provoking opinions and perspectives.

Immunological changes associated with the onset of atopic dermatitis and a primer on cost effectiveness in the allergy clinic


August 26, 2019

We are in the home stretch of the summer months. It will soon be Labor Day and we will be into football season and perhaps more relevant to us, fall weed season. I hope all of you have had an opportunity to peruse the August issue of the Annals of Allergy, Asthma and Immunology. We try to provide something for everyone along the clinical spectrum of our specialty. The emphasis this month is cutaneous allergy.  A review by Patrick Brunner, MD from New York provides an excellent overview of new information regarding the immunological changes associated with the onset of atopic dermatitis (AD). He presents information to suggest prenatal and antenatal changes in infants who were subsequently at risk to develop AD.

Reviewing comorbidities associated with atopic dermatitis and management of chronic pruritis.


August 12, 2019

Good August to everybody! School already has, or will soon start, for learners from kindergarten to medical school. The heat of the summer is in full blast in most of North America and many of us are getting ready for fall weed season. It is a very busy time for us all, yet we still are committed to providing the best care possible for our patients who depend upon us for relief from their allergies, asthma and immune-based illnesses. It remains an integral part of our lives to look for and digest new and important information that will help our clinical practices. That remains the central goal for the Annals of Allergy, Asthma and Immunology which presents this month a group of papers that will inform, educate and (at least a few) actually entertain you.

Evidence for using point-of-care ultrasonography as a clinical office tool, the venom immunotherapy shortages as an example of payment structure of medical services, and value of the ABAI MOC program


July 22, 2019

Most of us in North America are in the midst of the summer heat. This has made indoor (or at least shaded outdoor) activities a must for most of us. I can think of no better way to spend this time than having your favorite cool beverage while perusing the pages of the July issue of the Annals of Allergy, Asthma and Immunology. Although the emphasis for this month is drug allergy, in keeping with our efforts to provide something for everyone in every issue, I want to call your attention to a few articles that will expand your thinking.

Evaluation and management of drug allergy


July 8, 2019

For those reading this who reside in the United States I hope you had a great Fourth of July weekend as we celebrated our great country. For those living elsewhere, I hope your weekend was restful as well. The middle of summer is here in our northern hemisphere bringing hot weather, rain showers (or, in some places drought conditions) and drives many inside for relaxation/recreation. That provides an ideal time to sit with your favorite beverage and peruse the pages of the July Annals of Allergy, Asthma and Immunology. This month’s issue has an emphasis on drug allergy – evaluation and approaches to management.